CFAP94

Across TCGA pan-cancer cohorts, CFAP94 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated CFAP94 data layer compared with 25 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher CFAP94 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated CFAP94 expression acts as an unfavorable survival marker, although some lineages such as UCEC and STAD show a favorable association.

UCEC, SCLC, and LUSC are the cancer types where CFAP94 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.964	0.624	.011	12	view →
SCLC	OS	Median	All	0.082	0.822	<.001	6	view →
LUSC	OS	Median	All	0.081	0.818	<.001	6	view →
LUAD	OS	Median	All	0.251	0.700	.001	6	view →
STAD	DFS	Median	III,IV	1.000	0.338	.048	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

CFAP94–UCEC (DFS)

Open the UCEC breakdown →